...
首页> 外文期刊>BMC Complementary and Alternative Medicine >Mutagenicity and antimutagenicity of six Brazilian Byrsonima species assessed by the Ames test
【24h】

Mutagenicity and antimutagenicity of six Brazilian Byrsonima species assessed by the Ames test

机译:通过Ames试验评估的六个巴西Byrsonima物种的致突变性和抗致突变性

获取原文
           

摘要

Background In various regions of Brazil, several species of the genus Byrsonima (Malpighiaceae) are widely used to treat gastrointestinal complications. This genus has about 150 species of shrubs and trees distributed over the entire Neotropical region. Various biological activities have been identified in these plants, especially antioxidant, antimicrobial and topical and systemic anti-inflammatory activities. The aim of this study was to investigate the mutagenicity and antimutagenicity of hydroalcoholic leaf extracts of six species of Byrsonima: B. verbascifolia, B. correifolia, B. coccolobifolia, B. ligustrifolia, B. fagifolia and B. intermedia by the Salmonella microsome assay (Ames test). Methods Mutagenic and antimutagenic activity was assessed by the Ames test, with the Salmonella typhimurium tester strains TA100, TA98, TA97a and TA102, with (+S9) and without (-S9) metabolization, by the preincubation method. Results Only B. coccolobifolia and B. ligustrifolia showed mutagenic activity. However, the extracts of B. verbascifolia, B. correifolia, B. fagifolia and B. intermedia were found to be strongly antimutagenic against at least one of the mutagens tested. Conclusions These results contribute to valuable data on the safe use of medicinal plants and their potential chemopreventive effects. Considering the excellent antimutagenic activities extracted from B. verbascifolia, B. correifolia, B. fagifolia and B. intermedia, these extracts are good candidate sources of chemopreventive agents. However, B. coccolobifolia and B. ligustrifolia showed mutagenic activity, suggesting caution in their use.
机译:背景技术在巴西的各个地区,Byrsonima(Malpighiaceae)属的几种被广泛用于治疗胃肠道并发症。该属约有150种灌木和树木分布在整个新热带地区。在这些植物中已经鉴定出各种生物活性,特别是抗氧化剂,抗微生物以及局部和全身性抗炎活性。这项研究的目的是通过沙门氏菌微粒体分析法研究六种拜占庭属水藻叶片提取物的诱变性和抗致突变性:普通芽孢杆菌,B。correifolia,B。coccolobifolia,B。ligustrifolia,B。fagifolia和中间芽孢杆菌。 (埃姆斯测试)。方法采用预培养方法,通过鼠伤寒沙门氏菌测试株TA100,TA98,TA97a和TA102进行Ames试验,评估突变和抗突变活性。结果只有球孢双歧杆菌和女贞双歧杆菌具有诱变活性。然而,发现毛果芽孢杆菌,Correifolia芽孢杆菌,fafoliolia芽孢杆菌和中间芽孢杆菌的提取物对至少一种所测试的诱变剂具有强的抗诱变作用。结论这些结果为有关药用植物安全使用及其潜在的化学预防作用提供了有价值的数据。考虑到从藜芦芽孢杆菌,Correifolia芽孢杆菌,fagifolia芽孢杆菌和中间芽孢杆菌中提取的优异的抗诱变活性,这些提取物是化学预防剂的良好候选来源。然而,球孢双歧杆菌和女贞双歧杆菌显示出诱变活性,表明在使用时要谨慎。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号